Nanocarriers can be divided into two principal groups: organic and inorganic types. The organic group contains lipid nanocarriers, liposomes, polymeric nanoparticles, dendrimers, etc. In the case of the carriers in this group, the limited volume of delivered active pharmaceutical ingredient (API) is a clear disadvantage, along with decreased stability, and good sensitivity to temperature, pH, and enzymes in a physiological environment. The inorganic group contains metal oxide-, carbon-, silicon-, silica-, and quantum dot-based nanocarriers. Their benefits are greater stability and well-tunable physicochemical properties, but their accumulation in the body may be a key question of their applicability. Silica nanoparticles (SNP) are silicon dioxide (SiO 2 ) nanoparticles in an amorphous state and have excellent potential in the pharmaceutical industry and drug development due to their special properties. According to pore size, the most common, most well-liked, and most effective type of silica nanocarriers are the mesoporous silica nanoparticles (MSNs) [ 1 ].
Silica Demand in 2026: Key Industries Driving Growth
Silica Filler for CCL: How It Improves Copper Clad Laminate Performance
Silica for Printing Ink: Functions, Grades and Formulation Tips
BET Surface Area of Silica: Measurement Method and Typical Values by Grade
Data Availability Statement
Quechen Silica: Company Overview, Product Range and Applications
Silicon Dioxide Physical Properties: Melting Point, Hardness, Density and More
What is silica (SiO₂)?
diatomite
What is the difference between fumed silica and precipitated silica?
hydrophilic fumed silica
Nanoparticles (NPs) would naturally encounter some difficulties in accessing ideal targets. They can be deposited in non-target tissues due to physiological barriers, heterogeneity of receptor expression, and defective targeting mechanisms, and therefore become potentially toxic and less effective [ 80 ]. In addition, environment-sensitive systems responsive to environmental stimuli such as pH may be activated before their intended use, or in normal tissues if the same environmental circumstances are present, leading to unwanted release of the drug [ 81 ]. Biological heterogeneity of patients, i.e., immune factors such as anti-PEG antibodies, may influence the biodistribution of nanoparticles and off-target interactions as well [ 80 ].
What drives silica raw material prices?
TEOS
11. Ortiz A.C., Jackson N., Buelvas N., Jerez A., López-Muñoz R.A., Morales J., Arriagada F. Release kinetics approach of stimuli-responsive mesoporous silica nanocarriers: pH-sensitive linker versus pH-sensitive framework. J. Drug Deliv. Sci. Technol. 2024;91:105212. doi: 10.1016/j.jddst.2023.105212. [ DOI ] [ Google Scholar ]
Cite this article: Silica Raw Materials News. "High Purity Silica: Purity Levels (4N–6N), Specifications and Applications
." Published 2026-11-20 06:55:36. /news/article.html Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.